Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia
Latest Information Update: 05 Aug 2020
At a glance
- Drugs Imatinib (Primary) ; Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 07 Oct 2017 Planned initiation date changed from 1 Sep 2017 to 1 Dec 2017.
- 04 Aug 2017 Planned initiation date changed from 1 Aug 2017 to 1 Sep 2017.
- 27 Jul 2017 New trial record